Label:
ALTRIXA OB- beta-crotene, ascorbic acid, cholecalciferol, dl-alpha tocopherol acetate, pyridoxine hci, biotin, folic aci...
view full title

  • Category: DIETARY SUPPLEMENT
  • DEA Schedule: None
  • Marketing Status: Dietary Supplement

Drug Label Information

Updated May 30, 2025

If you are a consumer or patient please visit this version.

  • HEALTH CLAIM
    Altrixa OB Tablets - Dispensed by Prescription
  • STATEMENT OF IDENTITY
    Serving Size: 1 Tablet - Servings Per Container: 30 - Each Tablet Contains: %DV - Vitamin A (as beta-carotene)                      300 mcg RAE  - 66% Vitamin C (as ascorbic acid)  125 ...
  • Description
    Altrixa OB Tablets is a prescription dietary supplement for use throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing ...
  • CONTRADINDICATIONS
    Altrixa OB Tablets are contraindicted in patients with a known hypersensitivity to any of the contained ingredients.   Do not take this product if you are presently taking mineral oil, unless ...
  • WARNING
    Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In the case of accidental ...
  • ADVERSE REACTIONS
    Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You may report side effects by calling Allegis Pharmaceuticals, Inc at 1-866-633-9033 or ...
  • DOSAGE AND ADMINISTRATION
    Before, during and/or after pregnancy, one tablet daily with food or as directed by a physician.
  • PRECAUTION:
    Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure ...
  • How Supplied
    How Supplied - Altrixa OB Talets are available as white tablets with "225" embossed and are available in 30 count bottles (28595-721-30*). Manufactured in the USA for: Allegis Pharmaceuticals ...
  • Statements
    These statements have not been evaluated by the FDA.  This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not an Orange Book Product. Dispense by ...
  • STORAGE
    Store at 20°-25°C (68°-77°F) excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Protect from light - and moisture. Tamper evident: Do not use if seal is broken or ...
  • Label
    Label
  • INGREDIENTS AND APPEARANCE
    Product Information